Pregnancy outcomes following COVID-19 pregnancy in Thai women COVID-19, vaccination, pregnant, Thai
Conditions
Interventions
sinovac- astra (4wk interval),astra zeneca-astra zeneca (8wk interval),astra zeneca-astra zeneca (3-4wk interval),sinovac- pfizer (4wk interval),pfizer- pfizer (4wk interval)
Sinovac/Astra,Astra/astra,Astra/pfizer,sinovac/pfizer,pfizer/pfizer
Sponsors
National Research Council of Thailand (NRCT)
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Singleton pregnancy 2. Alive, intrauterine pregnancy 3. Gestational age >12 weeks 4. Literacy in Thai 5. Thai language literacy 6. Able to use applications e.g. Google form, Line 7. Able to comply follow-up schedules 8. Willing to participate in the study
Exclusion criteria
Exclusion criteria: 1. History of uterine bleeding >2 times in the current pregnancy 2. Having uterine bleeding on the enrollment day 3. History of or having pre-eclampsia, abnormal placental position, preterm labor, fetal growth restriction 4. History of cigarettes smoking, alcohol drinking, recreational drugs 5. Recent immunization in prior 14 days 6. Previous COVID-19 immunization 7. Detection of COVID-19 in prior 90 days 8. Blood transfusion in prior 90 days 9. History of severe drug hypersensitivity 10. Type 1, 2 diabetes mellitus 11. Hypertension 12. Having uncontrollable diseases 13. Immunocompromised conditions, including steroid use 14. Investigators' judgement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events Delivery Descriptive statistics | — |
Secondary
| Measure | Time frame |
|---|---|
| Antibody response Delivery Descriptive statistics | — |
Countries
Thailand
Contacts
Public ContactChenchit Chayachinda
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed